25 XP   0   0   10

American Cryostem Corp
Buy, Hold or Sell?

Let's analyse American Cryostem Corp together

PenkeI guess you are interested in American Cryostem Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of American Cryostem Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about American Cryostem Corp

I send you an email if I find something interesting about American Cryostem Corp.

Quick analysis of American Cryostem Corp (30 sec.)










What can you expect buying and holding a share of American Cryostem Corp? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.03
Expected worth in 1 year
$-0.12
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-0.09
Return On Investment
-89,859.5%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0001 - $0.0001
How sure are you?
50%

1. Valuation of American Cryostem Corp (5 min.)




Live pricePrice per Share (EOD)

$0.00

Intrinsic Value Per Share

$-0.06 - $0.01

Total Value Per Share

$-0.09 - $-0.02

2. Growth of American Cryostem Corp (5 min.)




Is American Cryostem Corp growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.8m-$421.1k-$1.4m-77.2%

How much money is American Cryostem Corp making?

Current yearPrevious yearGrowGrow %
Making money-$3m-$1.6m-$1.4m-46.6%
Net Profit Margin-14,620.8%-288.3%--

How much money comes from the company's main activities?

3. Financial Health of American Cryostem Corp (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

What can you expect buying and holding a share of American Cryostem Corp? (5 min.)

Welcome investor! American Cryostem Corp's management wants to use your money to grow the business. In return you get a share of American Cryostem Corp.

What can you expect buying and holding a share of American Cryostem Corp?

First you should know what it really means to hold a share of American Cryostem Corp. And how you can make/lose money.

Speculation

The Price per Share of American Cryostem Corp is $0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of American Cryostem Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in American Cryostem Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.03. Based on the TTM, the Book Value Change Per Share is $-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is $0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of American Cryostem Corp.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.05-47,721.4%-0.05-47,721.4%-0.02-22,828.0%-0.03-30,504.4%-0.04-38,090.8%
Usd Book Value Change Per Share-0.02-22,464.9%-0.02-22,464.9%0.0217,155.6%0.002,669.4%0.00-3,430.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.02-22,464.9%-0.02-22,464.9%0.0217,155.6%0.002,669.4%0.00-3,430.5%
Usd Price Per Share0.30-0.30-0.37-0.56-0.38-
Price to Earnings Ratio-6.29--6.29--16.21--19.95--11.93-
Price-to-Total Gains Ratio-13.35--13.35-21.57-23.28--54.13-
Price to Book Ratio-9.80--9.80--45.38--32.73--45.44-
Price-to-Total Gains Ratio-13.35--13.35-21.57-23.28--54.13-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0001
Number of shares10000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.00
Usd Total Gains Per Share-0.020.00
Gains per Quarter (10000000 shares)-224,648.7526,694.18
Gains per Year (10000000 shares)-898,595.01106,776.70
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-898595-8986050106777106767
20-1797190-17972000213553213544
30-2695785-26957950320330320321
40-3594380-35943900427107427098
50-4492975-44929850533884533875
60-5391570-53915800640660640652
70-6290165-62901750747437747429
80-7188760-71887700854214854206
90-8087355-80873650960990960983
100-8985950-8985960010677671067760

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%1.012.00.07.7%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%3.07.00.030.0%5.08.00.038.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.013.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%3.07.00.030.0%5.08.00.038.5%

Fundamentals of American Cryostem Corp

About American Cryostem Corp

American CryoStem Corporation develops, markets, and licenses adipose tissue derived technologies for use in the fields of Regenerative and Personalized Medicine. The company's products include CELLECT collection, transportation, and storage system, which is a solution for physicians to collect and deliver tissue samples; ATGRAFT adipose tissue storage service, a fat collection, processing, and storage solution that enables physicians to provide their patients with tissue products and cell storage options; and ATCELL adipose derived stem cells. It also offers ACSelerat cell culture media products for growing human stromal cells. In addition, the company, provides contract manufacturing services for Autokine-CM, an anti-aging topical formulation; and autologous skin care product line. American CryoStem Corporation was founded in 1987 and is based in Eatontown, New Jersey.

Fundamental data was last updated by Penke on 2024-05-15 22:23:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of American Cryostem Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit American Cryostem Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare American Cryostem Corp to the Biotechnology industry mean.
  • A Net Profit Margin of -14,620.8% means that $-146.21 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of American Cryostem Corp:

  • The MRQ is -14,620.8%. The company is making a huge loss. -2
  • The TTM is -14,620.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-14,620.8%TTM-14,620.8%0.0%
TTM-14,620.8%YOY-288.3%-14,332.5%
TTM-14,620.8%5Y-3,098.3%-11,522.5%
5Y-3,098.3%10Y-4,982.3%+1,884.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14,620.8%-177.0%-14,443.8%
TTM-14,620.8%-223.7%-14,397.1%
YOY-288.3%-256.7%-31.6%
5Y-3,098.3%-431.4%-2,666.9%
10Y-4,982.3%-551.3%-4,431.0%
1.1.2. Return on Assets

Shows how efficient American Cryostem Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare American Cryostem Corp to the Biotechnology industry mean.
  • -285.0% Return on Assets means that American Cryostem Corp generated $-2.85 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of American Cryostem Corp:

  • The MRQ is -285.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -285.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-285.0%TTM-285.0%0.0%
TTM-285.0%YOY-108.9%-176.1%
TTM-285.0%5Y-145.5%-139.5%
5Y-145.5%10Y-262.7%+117.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-285.0%-11.9%-273.1%
TTM-285.0%-11.7%-273.3%
YOY-108.9%-10.8%-98.1%
5Y-145.5%-13.0%-132.5%
10Y-262.7%-14.2%-248.5%
1.1.3. Return on Equity

Shows how efficient American Cryostem Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare American Cryostem Corp to the Biotechnology industry mean.
  • 0.0% Return on Equity means American Cryostem Corp generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of American Cryostem Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--15.1%+15.1%
TTM--14.7%+14.7%
YOY--13.3%+13.3%
5Y--17.6%+17.6%
10Y--19.1%+19.1%

1.2. Operating Efficiency of American Cryostem Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient American Cryostem Corp is operating .

  • Measures how much profit American Cryostem Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare American Cryostem Corp to the Biotechnology industry mean.
  • An Operating Margin of -10,710.6% means the company generated $-107.11  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of American Cryostem Corp:

  • The MRQ is -10,710.6%. The company is operating very inefficient. -2
  • The TTM is -10,710.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-10,710.6%TTM-10,710.6%0.0%
TTM-10,710.6%YOY-105.6%-10,605.0%
TTM-10,710.6%5Y-2,257.1%-8,453.5%
5Y-2,257.1%10Y-4,282.2%+2,025.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-10,710.6%-348.2%-10,362.4%
TTM-10,710.6%-232.7%-10,477.9%
YOY-105.6%-266.9%+161.3%
5Y-2,257.1%-412.2%-1,844.9%
10Y-4,282.2%-516.7%-3,765.5%
1.2.2. Operating Ratio

Measures how efficient American Cryostem Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 108.11 means that the operating costs are $108.11 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of American Cryostem Corp:

  • The MRQ is 108.106. The company is inefficient in keeping operating costs low. -1
  • The TTM is 108.106. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ108.106TTM108.1060.000
TTM108.106YOY2.056+106.050
TTM108.1065Y23.553+84.553
5Y23.55310Y45.444-21.891
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ108.1063.097+105.009
TTM108.1063.332+104.774
YOY2.0563.564-1.508
5Y23.5535.224+18.329
10Y45.4446.637+38.807

1.3. Liquidity of American Cryostem Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if American Cryostem Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.12 means the company has $0.12 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of American Cryostem Corp:

  • The MRQ is 0.121. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.121. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.121TTM0.1210.000
TTM0.121YOY0.540-0.420
TTM0.1215Y0.324-0.204
5Y0.32410Y0.225+0.099
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1213.798-3.677
TTM0.1214.146-4.025
YOY0.5405.212-4.672
5Y0.3246.093-5.769
10Y0.2256.441-6.216
1.3.2. Quick Ratio

Measures if American Cryostem Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare American Cryostem Corp to the Biotechnology industry mean.
  • A Quick Ratio of 0.05 means the company can pay off $0.05 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of American Cryostem Corp:

  • The MRQ is 0.053. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.053. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.053TTM0.0530.000
TTM0.053YOY0.516-0.463
TTM0.0535Y0.281-0.227
5Y0.28110Y0.197+0.084
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0533.165-3.112
TTM0.0533.776-3.723
YOY0.5165.140-4.624
5Y0.2815.839-5.558
10Y0.1976.367-6.170

1.4. Solvency of American Cryostem Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of American Cryostem Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare American Cryostem Corp to Biotechnology industry mean.
  • A Debt to Asset Ratio of 2.75 means that American Cryostem Corp assets are financed with 274.9% credit (debt) and the remaining percentage (100% - 274.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of American Cryostem Corp:

  • The MRQ is 2.749. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.749. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.749TTM2.7490.000
TTM2.749YOY1.285+1.464
TTM2.7495Y1.911+0.838
5Y1.91110Y2.312-0.401
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7490.340+2.409
TTM2.7490.341+2.408
YOY1.2850.279+1.006
5Y1.9110.366+1.545
10Y2.3120.380+1.932
1.4.2. Debt to Equity Ratio

Measures if American Cryostem Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare American Cryostem Corp to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of American Cryostem Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.388-0.388
TTM-0.415-0.415
YOY-0.356-0.356
5Y-0.443-0.443
10Y-0.469-0.469

2. Market Valuation of American Cryostem Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings American Cryostem Corp generates.

  • Above 15 is considered overpriced but always compare American Cryostem Corp to the Biotechnology industry mean.
  • A PE ratio of -6.29 means the investor is paying $-6.29 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of American Cryostem Corp:

  • The EOD is -0.002. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.286. Based on the earnings, the company is expensive. -2
  • The TTM is -6.286. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.002MRQ-6.286+6.284
MRQ-6.286TTM-6.2860.000
TTM-6.286YOY-16.208+9.922
TTM-6.2865Y-19.945+13.659
5Y-19.94510Y-11.931-8.014
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.002-2.289+2.287
MRQ-6.286-2.558-3.728
TTM-6.286-2.723-3.563
YOY-16.208-3.900-12.308
5Y-19.945-6.368-13.577
10Y-11.931-6.544-5.387
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of American Cryostem Corp:

  • The EOD is -0.015. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -45.798. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -45.798. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.015MRQ-45.798+45.783
MRQ-45.798TTM-45.7980.000
TTM-45.798YOY-36.243-9.555
TTM-45.7985Y-4.182-41.617
5Y-4.18210Y-7.131+2.950
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.015-3.247+3.232
MRQ-45.798-3.308-42.490
TTM-45.798-3.522-42.276
YOY-36.243-5.154-31.089
5Y-4.182-8.005+3.823
10Y-7.131-8.608+1.477
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of American Cryostem Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -9.80 means the investor is paying $-9.80 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of American Cryostem Corp:

  • The EOD is -0.003. Based on the equity, the company is expensive. -2
  • The MRQ is -9.798. Based on the equity, the company is expensive. -2
  • The TTM is -9.798. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.003MRQ-9.798+9.795
MRQ-9.798TTM-9.7980.000
TTM-9.798YOY-45.380+35.582
TTM-9.7985Y-32.735+22.937
5Y-32.73510Y-45.440+12.705
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0031.996-1.999
MRQ-9.7982.027-11.825
TTM-9.7982.073-11.871
YOY-45.3802.696-48.076
5Y-32.7353.727-36.462
10Y-45.4404.109-49.549
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of American Cryostem Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.022-0.0220%0.017-231%0.003-942%-0.003-85%
Book Value Per Share---0.031-0.0310%-0.008-73%-0.020-33%-0.021-31%
Current Ratio--0.1210.1210%0.540-78%0.324-63%0.225-46%
Debt To Asset Ratio--2.7492.7490%1.285+114%1.911+44%2.312+19%
Debt To Equity Ratio----0%-0%-0%-0%
Dividend Per Share----0%-0%-0%-0%
Eps---0.048-0.0480%-0.023-52%-0.031-36%-0.038-20%
Free Cash Flow Per Share---0.007-0.0070%-0.010+56%-0.006-6%-0.012+82%
Free Cash Flow To Equity Per Share---0.001-0.0010%0.000-260%0.001-143%0.000-215%
Gross Profit Margin--1.0021.0020%1.016-1%1.024-2%1.020-2%
Intrinsic Value_10Y_max--0.014--------
Intrinsic Value_10Y_min---0.062--------
Intrinsic Value_1Y_max---0.005--------
Intrinsic Value_1Y_min---0.011--------
Intrinsic Value_3Y_max---0.009--------
Intrinsic Value_3Y_min---0.028--------
Intrinsic Value_5Y_max---0.008--------
Intrinsic Value_5Y_min---0.042--------
Market Cap4427.930-408725%18102473.40018102473.4000%19114023.510-5%27094657.940-33%17713568.307+2%
Net Profit Margin---146.208-146.2080%-2.883-98%-30.983-79%-49.823-66%
Operating Margin---107.106-107.1060%-1.056-99%-22.571-79%-42.822-60%
Operating Ratio--108.106108.1060%2.056+5158%23.553+359%45.444+138%
Pb Ratio-0.003+100%-9.798-9.7980%-45.380+363%-32.735+234%-45.440+364%
Pe Ratio-0.002+100%-6.286-6.2860%-16.208+158%-19.945+217%-11.931+90%
Price Per Share0.000-299900%0.3000.3000%0.370-19%0.564-47%0.376-20%
Price To Free Cash Flow Ratio-0.015+100%-45.798-45.7980%-36.243-21%-4.182-91%-7.131-84%
Price To Total Gains Ratio-0.004+100%-13.354-13.3540%21.567-162%23.275-157%-54.134+305%
Quick Ratio--0.0530.0530%0.516-90%0.281-81%0.197-73%
Return On Assets---2.850-2.8500%-1.089-62%-1.455-49%-2.627-8%
Return On Equity----0%-0%-0%-0%
Total Gains Per Share---0.022-0.0220%0.017-231%0.003-942%-0.003-85%
Usd Book Value---1847553.000-1847553.0000%-421199.000-77%-1045752.200-43%-1000422.900-46%
Usd Book Value Change Per Share---0.022-0.0220%0.017-231%0.003-942%-0.003-85%
Usd Book Value Per Share---0.031-0.0310%-0.008-73%-0.020-33%-0.021-31%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.048-0.0480%-0.023-52%-0.031-36%-0.038-20%
Usd Free Cash Flow---395265.000-395265.0000%-527379.000+33%-321795.200-19%-551451.700+40%
Usd Free Cash Flow Per Share---0.007-0.0070%-0.010+56%-0.006-6%-0.012+82%
Usd Free Cash Flow To Equity Per Share---0.001-0.0010%0.000-260%0.001-143%0.000-215%
Usd Market Cap4427.930-408725%18102473.40018102473.4000%19114023.510-5%27094657.940-33%17713568.307+2%
Usd Price Per Share0.000-299900%0.3000.3000%0.370-19%0.564-47%0.376-20%
Usd Profit---3010423.000-3010423.0000%-1608666.000-47%-1711761.000-43%-1867157.300-38%
Usd Revenue--20590.00020590.0000%557903.000-96%773784.200-97%495561.800-96%
Usd Total Gains Per Share---0.022-0.0220%0.017-231%0.003-942%-0.003-85%
 EOD+2 -6MRQTTM+0 -0YOY+5 -275Y+2 -3010Y+8 -24

3.2. Fundamental Score

Let's check the fundamental score of American Cryostem Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.002
Price to Book Ratio (EOD)Between0-1-0.003
Net Profit Margin (MRQ)Greater than0-146.208
Operating Margin (MRQ)Greater than0-107.106
Quick Ratio (MRQ)Greater than10.053
Current Ratio (MRQ)Greater than10.121
Debt to Asset Ratio (MRQ)Less than12.749
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-2.850
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of American Cryostem Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.230
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2021-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets1,056
Total Liabilities2,904
Total Stockholder Equity-1,848
 As reported
Total Liabilities 2,904
Total Stockholder Equity+ -1,848
Total Assets = 1,056

Assets

Total Assets1,056
Total Current Assets197
Long-term Assets859
Total Current Assets
Cash And Cash Equivalents 8
Net Receivables 79
Inventory 18
Other Current Assets 92
Total Current Assets  (as reported)197
Total Current Assets  (calculated)197
+/-0
Long-term Assets
Property Plant Equipment 229
Long Term Investments 245
Intangible Assets 372
Other Assets 14
Long-term Assets  (as reported)859
Long-term Assets  (calculated)859
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,631
Long-term Liabilities1,273
Total Stockholder Equity-1,848
Total Current Liabilities
Short-term Debt 858
Short Long Term Debt 823
Accounts payable 553
Other Current Liabilities 98
Total Current Liabilities  (as reported)1,631
Total Current Liabilities  (calculated)2,332
+/- 701
Long-term Liabilities
Long term Debt 281
Capital Lease Obligations 46
Other Liabilities 980
Long-term Liabilities  (as reported)1,273
Long-term Liabilities  (calculated)1,307
+/- 35
Total Stockholder Equity
Common Stock61
Retained Earnings -19,278
Other Stockholders Equity 17,369
Total Stockholder Equity (as reported)-1,848
Total Stockholder Equity (calculated)-1,848
+/-0
Other
Capital Stock61
Cash and Short Term Investments 8
Common Stock Shares Outstanding 60,342
Current Deferred Revenue122
Liabilities and Stockholders Equity 1,056
Net Debt 1,142
Net Invested Capital -743
Net Tangible Assets -2,219
Net Working Capital -1,434
Property Plant and Equipment Gross 518
Short Long Term Debt Total 1,151



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-302009-09-30
> Total Assets 
70
60
561
460
569
540
534
592
1,009
1,266
1,294
1,477
1,056
1,0561,4771,2941,2661,0095925345405694605616070
   > Total Current Assets 
8
2
125
4
118
82
73
127
643
369
380
567
197
1975673803696431277382118412528
       Cash And Cash Equivalents 
8
2
107
4
116
21
9
37
410
68
24
42
8
842246841037921116410728
       Net Receivables 
0
0
0
0
2
6
57
65
172
218
330
500
79
795003302181726557620000
       Other Current Assets 
0
2
18
0
0
54
8
0
33
49
0
5
92
925049330854001820
   > Long-term Assets 
61
59
436
456
451
458
460
465
366
897
914
910
859
8599109148973664654604584514564365961
       Property Plant Equipment 
61
59
334
319
281
250
211
183
52
245
238
230
229
229230238245521832112502813193345961
       Long Term Investments 
0
0
0
0
0
1
1
1
1
301
300
300
245
245300300301111100000
       Intangible Assets 
0
0
99
126
164
201
240
257
299
338
362
366
372
3723663623382992572402011641269900
       Other Assets 
0
0
3
11
6
7
8
24
14
14
14
14
14
14141414142487611300
> Total Liabilities 
8
0
398
484
622
1,661
2,165
2,539
2,031
1,967
2,532
1,898
2,904
2,9041,8982,5321,9672,0312,5392,1651,66162248439808
   > Total Current Liabilities 
8
0
145
261
280
1,496
1,997
1,273
1,922
1,112
1,292
1,050
1,631
1,6311,0501,2921,1121,9221,2731,9971,49628026114508
       Short-term Debt 
0
0
0
0
20
780
1,133
413
1,091
581
661
844
858
8588446615811,0914131,133780200000
       Short Long Term Debt 
0
0
0
0
0
173
557
413
1,091
550
625
799
823
8237996255501,09141355717300000
       Accounts payable 
0
0
128
241
260
698
807
832
223
474
322
182
553
55318232247422383280769826024112800
       Other Current Liabilities 
8
0
145
261
260
698
807
832
806
31
286
24
98
98242863180683280769826026114508
   > Long-term Liabilities 
0
0
253
223
341
165
168
1,266
109
855
1,240
848
1,273
1,2738481,2408551091,26616816534122325300
       Other Liabilities 
0
0
0
0
0
0
0
0
420
660
900
740
980
98074090066042000000000
> Total Stockholder Equity
62
60
163
-24
-52
-1,121
-1,631
-1,947
-1,022
-700
-1,238
-421
-1,848
-1,848-421-1,238-700-1,022-1,947-1,631-1,121-52-241636062
   Common Stock
5
6
26
28
32
33
35
37
43
48
49
60
61
616049484337353332282665
   Retained Earnings Total Equity0000000000000
   Accumulated Other Comprehensive Income 
12
-21
-12
-78
-116
-155
-194
-230
-265
-287
-289
0
0
00-289-287-265-230-194-155-116-78-12-2112
   Capital Surplus 0000000000000
   Treasury Stock0000000000000
   Other Stockholders Equity 
44
76
1,461
3,701
6,107
7,165
8,071
9,670
11,847
13,675
13,932
15,917
17,369
17,36915,91713,93213,67511,8479,6708,0717,1656,1073,7011,4617644



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-09-30)

Gross Profit (+$)
totalRevenue21
Cost of Revenue-14
Gross Profit77
 
Operating Income (+$)
Gross Profit7
Operating Expense-2,212
Operating Income-2,205-2,205
 
Operating Expense (+$)
Research Development447
Selling General Administrative1,759
Selling And Marketing Expenses6
Operating Expense2,2122,212
 
Net Interest Income (+$)
Interest Income0
Interest Expense-104
Other Finance Cost-0
Net Interest Income-104
 
Pretax Income (+$)
Operating Income-2,205
Net Interest Income-104
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,880-1,531
EBIT - interestExpense = -2,309
-2,880
-2,907
Interest Expense104
Earnings Before Interest and Taxes (EBIT)-2,205-2,776
Earnings Before Interest and Taxes (EBITDA)-2,110
 
After tax Income (+$)
Income Before Tax-2,880
Tax Provision-0
Net Income From Continuing Ops-2,880-2,880
Net Income-3,010
Net Income Applicable To Common Shares-2,880
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,226
Total Other Income/Expenses Net-674104
 

Technical Analysis of American Cryostem Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of American Cryostem Corp. The general trend of American Cryostem Corp is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine American Cryostem Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of American Cryostem Corp.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0001 < 0.0001 < 0.0001.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Tweet this
American Cryostem Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of American Cryostem Corp. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I